Insights

Industry Leadership Cryoport Systems has established a strong reputation in the global cell and gene therapy supply chain sector, evidenced by their recent award for Supply Chain Excellence and continuous development of innovative cryogenic shipping systems. This positions them as a trusted provider for biotech firms seeking reliable logistics and storage solutions.

Strategic Partnerships Recent collaborations with TMRW Life Sciences and Minaris Regenerative Medicine highlight opportunities to expand service offerings in fertility and regenerative medicine markets, presenting avenues for targeted sales pitches relating to specialized specimen management and cryopreservation services.

Facility Expansion The significant expansion of their facilities in France and the launch of new cryopreservation services in Houston suggest a strategic focus on scaling operations and increasing capacity, which could be leveraged to attract new clients needing high-volume storage, logistics, and clinical sample management.

Technological Innovation Cryoport's ongoing development of high-volume cryogenic shipping systems and automation platforms indicates a commitment to cutting-edge technology, providing opportunities to offer complementary tech solutions or upgrades to existing clients interested in enhancing cold chain reliability.

Financial Investment & Growth With significant funding of $25 million despite current modest revenue, Cryoport is positioned for accelerated growth and market penetration. This makes them a compelling target for sales efforts aimed at expanding their client base within the growing biopharma and personalized medicine sectors.

Cell&Co BioServices Tech Stack

Cell&Co BioServices uses 8 technology products and services including Facebook Pixel, AutoCAD, Kubernetes, and more. Explore Cell&Co BioServices's tech stack below.

  • Facebook Pixel
    Analytics
  • AutoCAD
    Cad & Graphics
  • Kubernetes
    Containerization
  • Cloudflare CDN
    Content Delivery Network
  • MySQL
    Database
  • Selenium
    Frameworks And Libraries
  • CSS
    Web Tools And Plugins
  • Google Plus
    Widgets

Media & News

Cell&Co BioServices's Email Address Formats

Cell&Co BioServices uses at least 2 format(s):
Cell&Co BioServices Email FormatsExamplePercentage
FLast@cell-and-co.comJDoe@cell-and-co.com
96%
FirLast@cell-and-co.comJohDoe@cell-and-co.com
4%
FLast@cryoport.comJDoe@cryoport.com
93%
First.Last@cryoport.comJohn.Doe@cryoport.com
4%
LastFirst@cryoport.comDoeJohn@cryoport.com
2%
First_Last@cryoport.comJohn_Doe@cryoport.com
1%

Frequently Asked Questions

What is Cell&Co BioServices's official website and social media links?

Minus sign iconPlus sign icon
Cell&Co BioServices's official website is cryoport.com and has social profiles on LinkedIn.

How much revenue does Cell&Co BioServices generate?

Minus sign iconPlus sign icon
As of December 2025, Cell&Co BioServices's annual revenue is estimated to be $3.8M.

What is Cell&Co BioServices's NAICS code?

Minus sign iconPlus sign icon
Cell&Co BioServices's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cell&Co BioServices have currently?

Minus sign iconPlus sign icon
As of December 2025, Cell&Co BioServices has approximately 201 employees across 2 continents, including EuropeNorth America. Key team members include President – Co-Founder – Cfo & Cso: S. D.Data Manager: M. D.Project Manager: K. Z.. Explore Cell&Co BioServices's employee directory with LeadIQ.

What industry does Cell&Co BioServices belong to?

Minus sign iconPlus sign icon
Cell&Co BioServices operates in the Pharmaceutical Manufacturing industry.

What technology does Cell&Co BioServices use?

Minus sign iconPlus sign icon
Cell&Co BioServices's tech stack includes Facebook PixelAutoCADKubernetesCloudflare CDNMySQLSeleniumCSSGoogle Plus.

What is Cell&Co BioServices's email format?

Minus sign iconPlus sign icon
Cell&Co BioServices's email format typically follows the pattern of FLast@cell-and-co.com. Find more Cell&Co BioServices email formats with LeadIQ.

How much funding has Cell&Co BioServices raised to date?

Minus sign iconPlus sign icon
As of December 2025, Cell&Co BioServices has raised $25M in funding. The last funding round occurred on Dec 17, 2018 for $25M.

When was Cell&Co BioServices founded?

Minus sign iconPlus sign icon
Cell&Co BioServices was founded in 2012.

Cell&Co BioServices

Pharmaceutical ManufacturingAuvergne-rhône-alpes, France201-500 Employees

Cryoport Systems is a comprehensive supply chain partner for the life sciences industry focused on meeting the challenges of the global cell and gene therapy market. We excel in the specialized management of the biopharmaceutical supply chain through our comprehensive offerings in logistics, BioServices and biostorage, cryopreservation, and consulting. Our expansive offerings are fully integrated to create a comprehensive platform that helps deliver risk mitigation, transparency, and certainty. With our expansive platform and decades of temperature-controlled supply chain expertise, Cryoport Systems helps Enable the Outcome for organizations from initial research through global commercialization.

Our facility in Clermont-Ferrand is designed to solve industry challenges by helping to drive efficiency and scale for clients so they can devote more of their efforts toward the discovery and development of personalized therapies to treat patients around the world.
•	Clinical sample management and central laboratory services
•	Patient sample processing, testing, and centralized management
•	Custom kit production for sample collection
•	Biostorage for secure management and storage of patient samples
•	Laboratory dedicated to pre-analytical activities, including sample preparation, such as PBMC isolation, aliquoting, and extractions (plasma, serum, etc)

Our Pont-du-Chateau location (formerly Cell & Co) has recently expanded to support additional clinical and commercial packaging, labelling, and kitting services at scale.
•	GMP Biorepository for clinical and commercial products
•	Regulatory & Qualified Person (QP) services including importation and QP release
•	Drug packaging, labelling, and distribution for clinical and commercial pharmaceutical products

✉ cnc-contact@cryoport.com

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
201-500

Section iconFunding & Financials

  • $25M

    Cell&Co BioServices has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Dec 17, 2018 in the amount of $25Mas a investment.

  • $1M

    Cell&Co BioServices's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $25M

    Cell&Co BioServices has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Dec 17, 2018 in the amount of $25Mas a investment.

  • $1M

    Cell&Co BioServices's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.